glp 1 drugs for inflammation Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent Health Feed - Glp-1 Drugs

This reduces the risk of hypoglycemia compared to some other diabetes medications

& Shannon, R

GLP-1RAs exert glycemic control through multiple mechanisms, including the stimulation of insulin secretion under hyperglycemic conditions, suppression of glucagon secretion during hyperglycemia, deceleration of gastric emptying to mitigate postprandial glucose spikes, reduction of caloric intake, and promotion of weight loss.71,8183 Short-acting GLP-1RAs, such as exenatide and lixisenatide, primarily reduce nocturnal and fasting glucose levels, while maintaining their effect on gastric emptying over prolonged treatment periods

The association between acne vulgaris and the use of GLP-1 RAs is still unclear

2014;12(3):38293 e1:quiz e22

[DOI] [PubMed] [Google Scholar] 105